Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Biomarkers in Multiple Myeloma [NA]
Recruitment is ongoing for a biomarker-focused clinical trial in newly diagnosed multiple myeloma patients, sponsored by Centre Hospitalier …
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Multi-center Screening for Serum M Protein
A multi-center screening trial is planned to screen for serum M protein in subjects with Monoclonal gammopathy and Multiple myeloma; recruit…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: VitD3 Supplementation in Patients With Multiple Myeloma [EARLY_Phase 1]
A Phase 1 early trial evaluating Vitamin D3 (cholecalciferol) supplementation in patients with multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating sequential BCMA-targeted CAR-T cell therapy after autologous stem cell transplantation in transplant-eligi…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: CAR-T Cell Therapy Combined With Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 clinical trial is evaluating a combination of CAR-T cell therapy with an allogeneic hematopoietic stem cell transplant for relapse…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
This clinical trial update describes evaluating MALDI-TOF mass spectrometry for screening and monitoring treatment response in multiple myel…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." [Phase 2]
Phase 2 open-label multicenter trial evaluating ixazomib, iberdomide, and dexamethasone in elderly patients with multiple myeloma at first r…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 trials are evaluating CAR-T cell therapy for relapsed or refractory malignant hematologic tumors, including aggressi…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients [Phase 2]
Phase 2 clinical trial evaluating the triplet regimen ixazomib plus lenalidomide plus dexamethasone in newly diagnosed multiple myeloma; sta…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating Purinostat Mesylate in combination with pomalidomide and low-dose dexamethasone in relapsed o…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment
The study evaluated real-world current standards of care for relapsed/refractory multiple myeloma patients who have received at least three …
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory T(11;14) Multiple Myeloma [Phase 1, Phase 2]
Clinical trial update announcing a Phase 1/2 study of belantamab mafodotin plus venetoclax for relapsed/refractory t(11;14) multiple myeloma…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Whole Body MRI in Oncology
This clinical trial update describes a study evaluating whole-body MRI in oncology across multiple cancer types, currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HLX15-IV Versus DARZALEX® in Combination with Lenalidomide-Dexamethasone (Rd) in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 study evaluating HLX15-IV versus DARZALEX in combination with lenalidomide-dexamethasone for transplant-ineligible newly diagnosed m…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma. [EARLY_Phase 1]
A Phase 1 clinical trial to evaluate the safety and efficacy of ESO-T01 for relapsed/refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Multiple Myeloma is a Hematologic Malignancy Characterized by the Accumulation of Malignant Plasma Cells in the Bone Marrow. Despite Advances in Treatment, Many Patients Experience Disease Relapse. Bispecific Antibodies Offer an Innovative Therapeutic Approach, But Approximately 30%-40% of Patients
This clinical trial update notes that multiple myeloma remains a relapse-prone hematologic malignancy and highlights bispecific antibodies a…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) [NA]
A CARTIER clinical trial is evaluating cardiovascular prevention strategies in elderly cancer patients and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma [NA]
This clinical trial update indicates that the LCAR-M61SQ therapy for relapsed/refractory multiple myeloma is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients [Phase 2]
Phase 2 clinical trial evaluating low-dose teclistamab in newly diagnosed multiple myeloma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study [Phase 2, Phase 3]
The REMNANT study is a phase 2/3 clinical trial for multiple myeloma conducted at Oslo University Hospital, currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients [Phase 2]
Phase 2 clinical trial evaluating selinexor with alternating bortezomib or lenalidomide plus dexamethasone in newly diagnosed multiple myelo…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: KPD Consolidation After ASCT in NDMM Patients [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating consolidation with the KPD regimen after autologous stem cell transp…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment
A real-world study in patients with multiple myeloma on treatment to map antithrombotic regimens.
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Role of Uromodulin in Management of Multiple Myloma [NA]
This entry reports a clinical trial from Assiut University investigating the role of uromodulin in the management of multiple myeloma; the s…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
A completed Canadian real-world study examining the burden of multiple myeloma on patients and the subjective burden and quality of life for…